Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results
Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both
Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both
Support for biologics manufacturability and Industry 4.0 initiatives
Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in record speed
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
The launch is yet another first of its kind innovation in India
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
The main aim of the challenge is to encourage early-stage start-ups and individuals working on innovations in Ayurveda and other alternative healing and medicine systems
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
Subscribe To Our Newsletter & Stay Updated